Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT02958111 · UNKNOWN
Trial details
- NCT number
- NCT02958111
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2021-12-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.